Show simple item record

Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer

dc.contributor.authorKOCATAS, Ali
dc.contributor.authorAykan, Nuri Faruk
dc.contributor.authorKarabulut, Senem
dc.contributor.authorOguz, HİLAL
dc.contributor.authorKARABULUT, Mehmet
dc.contributor.authorALIS, Halil
dc.contributor.authorAFSAR, Cigdem Usul
dc.date.accessioned2021-03-04T08:17:14Z
dc.date.available2021-03-04T08:17:14Z
dc.identifier.citationKARABULUT M., ALIS H., AFSAR C. U. , Karabulut S., KOCATAS A., Oguz H., Aykan N. F. , "Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer", BIOMEDICINE & PHARMACOTHERAPY, cilt.73, ss.140-146, 2015
dc.identifier.issn0753-3322
dc.identifier.otherav_628f6f50-93c3-4884-bfd6-1c84ee2a6ba8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/68643
dc.identifier.urihttps://doi.org/10.1016/j.biopha.2015.06.010
dc.description.abstractBackground: Neural precursor cell-expressed, developmentally down regulated 9 (NEDD9), a member of Crk-associated substrate (CAS) family, is highly expressed in multiple cancer types and involved in cancer cell adhesion, migration and invasion. The prognostic value of NEDD9 has been evaluated before and its expression is a predictor of poor prognosis in cancer patients. The objective of this study was to determine the clinical significance of the serum levels of NEDD9 in gastric cancer (GC) patients.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.titleSerum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer
dc.typeMakale
dc.relation.journalBIOMEDICINE & PHARMACOTHERAPY
dc.contributor.departmentIstanbul Bakurky Dr Sadi Konuk Educ & Res Hosp , ,
dc.identifier.volume73
dc.identifier.startpage140
dc.identifier.endpage146
dc.contributor.firstauthorID101680


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record